Hit enter to search or ESC to close
Sigrid Therapeutics
  • About Us
    • Our Story
    • The Team
    • Board of Directors
    • Advisory Board
  • R&D
    • SiPore®
    • Clinical Trials
    • Prediabetes
    • Pipeline
    • Posters & Publications
  • Resources
    • Logo
  • News
    • Media
    • Blog (English)
    • Blogs (Swedish)
    • Photos
  • Contact Us
  • Consumer Prelaunch Program
  • White paper
Sigrid Therapeutics
News

Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advisory Board

World-renowned oral healthcare expert joins Sigrid’s SAB to investigate impact of the SiPore® technology on…
Sana
SanaMay 10, 2023
News

Sigrid Therapeutics unveils SiPore® plaque blocker at IDS 2023

Sigrid Therapeutics unveils SiPore® to prevent oral pathogenic bacterial growth and plaque formation at International…
Sana
SanaMarch 14, 2023
News

Sigrid Therapeutics rapporterar positiva resultat från konsumenttest av SiPore®, en produkt avsedd för prediabetiker, typ 2-diabetiker och överviktiga för kontroll av blodsockernivån

Produkten, som tas i form av kapsel eller gel förhindrar att en del av matsmältningsenzymerna…
Sana
SanaMarch 8, 2023
News

Sigrid Therapeutics reports positive results from consumer blood sugar management trial using SiPore® formulated dietary supplements in pre-diabetics, type 2 diabetics, and obese individuals

“Molecular sieves” swallowed in capsules and gels reported safe, easy to digest and effective Stockholm,…
Sana
SanaMarch 8, 2023
News

Sigrid Therapeutics tar in ytterligare 10,6 miljoner kronor i övertecknad företrädesemission för att påskynda kommersialiseringen av SiPore®

Sigrid Therapeutics tar in ytterligare 10,6 miljoner kronor i övertecknad företrädesemission för att påskynda kommersialiseringen…
Sana
SanaJanuary 17, 2023
News

Sigrid Therapeutics raises further SEK10.6 million in oversubscribed rights issue for accelerated SiPore® commercialization

Sigrid Therapeutics raises further SEK10.6 million in oversubscribed rights issue for accelerated SiPore® commercialization Swedish…
Sana
SanaJanuary 17, 2023
News

Sigrid Therapeutics utser Mattias Ankerberg, en internationell ledarprofil från konsumentvarubranschen till ordförande

Sigrid Therapeutics utser Mattias Ankerberg, en internationell ledarprofil från konsumentvarubranschen till ordförande Företaget siktar mot…
Sana
SanaOctober 24, 2022
News

Sigrid Therapeutics appoints internationally established consumer industry executive Mattias Ankarberg as Chairman

Sigrid Therapeutics appoints internationally established consumer industry executive Mattias Ankarberg as Chairman Company aims to…
Sana
SanaOctober 24, 2022
News

Sigrid Therapeutics siktar mot konsumentmarknaden – erbjuder gratis testning av kliniskt bevisad produkt mot fetma och diabetes inför lansering

Sana
SanaJune 1, 2022
News

Nyutvecklad behandling mot fetma och diabetes

Sana
SanaJune 1, 2022
Next Entries »

© 2023 Sigrid Therapeutics.

    • About Us
      • Our Story
      • The Team
      • Board of Directors
      • Advisory Board
    • R&D
      • SiPore®
      • Clinical Trials
      • Prediabetes
      • Pipeline
      • Posters & Publications
    • Resources
      • Logo
    • News
      • Media
      • Blog (English)
      • Blogs (Swedish)
      • Photos
    • Contact Us
    • Consumer Prelaunch Program
    • White paper